Literature DB >> 8931690

Absence of association between the Gly40-->Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance.

M Odawara1, Y Tachi, K Yamashita.   

Abstract

We investigated whether a G123-->A mutation causing a Gly40-->Ser substitution in exon 2 of the human glucagon receptor gene, which has been reported to be associated with non-insulin-dependent diabetes mellitus (NIDDM) and impaired glucose tolerance (IGT) in France and Sardinia with a prevalences as high as 4.6% and 8.3%, respectively, is associated with Japanese patients with glucose intolerance. This mutation was not found in 242 unrelated Japanese patients with NIDDM or 23 with IGT by screening by the polymerase chain reaction-restriction fragment length polymorphism method. We also performed single-stranded conformational polymorphism analysis to search for new mutations in this gene associated with glucose intolerance. We found no mutations by examining all the 13 exons from 30 selected patients with NIDDM who had at least 2 diabetic first-degree relatives. These patients were also screened for the common polymorphism at codon 155 reported previously, but none were found to carry it. The absence of the mutation and polymorphism, which are common in French and Sardinian NIDDM or IGT patients, in Japanese indicates the existence of marked ethnic differences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931690     DOI: 10.1007/s004390050274

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  4 in total

1.  Factor V Leiden mutation and Japanese NIDDM.

Authors:  M Odawara; K Yamashita
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

2.  Foxa3 (HNF-3gamma) binds to and activates the rat proglucagon gene promoter but is not essential for proglucagon gene expression.

Authors:  Yuanfang Liu; Wei Shen; Patricia L Brubaker; Klaus H Kaestner; Daniel J Drucker
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

3.  Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.

Authors:  Cuiqi Zhou; Deepti Dhall; Nicholas N Nissen; Chun-Rong Chen; Run Yu
Journal:  Pancreas       Date:  2009-11       Impact factor: 3.327

Review 4.  Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes.

Authors:  Yunbo Jia; Yang Liu; Linlin Feng; Siyu Sun; Guangwei Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.